Skip to main content

LifeMD, Inc.

LFMD
Exchange
Nasdaq
Industry
Services-Offices & Clinics of Doctors of Medicine
SEC CIK
0000948320

No open-market purchases or sales by LifeMD, Inc. insiders were filed in the last 90 days; 116 institutions reported holding it in 13F filings for Q2 2026, worth $89.4M in total; no superinvestor holds it.

Other share classesLFMDP

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +16 vs. previous quarter
116
13F valueReported value at the end of Q2 2026
$89.4M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding LFMD, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding LFMD at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by LifeMD, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 11, 2025 (view filing)Dec 92 daysFriedeman JessicaChief Marketing OfficerSSale−15.0K$3.61−$54.1K−6.8%205.0K after
Sep 12, 2025 (view filing)Sep 102 daysAlvarez Nicholas PChief Acquisition OfficerSSale−75.0K$5.92−$444.0K−11.0%605.0K after
Aug 5, 2025 (view filing)Jul 135 daysLateSchreiber JustinChairman and CEOSSale−25.0K$9.99−$249.8K−1.0%2.48M after10b5-1
Jul 3, 2025 (view filing)Jul 12 daysSchreiber JustinChairman and CEOSSale−25.0K$13.38−$334.5K−1.0%2.50M after10b5-1
Jun 18, 2025 (view filing)Jun 16-172 daysBenathen Marc DavidChief Financial OfficerSSale−125.0K$13.46−$1.68M−26.9%339.6K after2 lots10b5-1
Jun 17, 2025 (view filing)Jun 134 daysYecies Eric HaroldChief Legal Officer & GCSSale−15.0K$12.25−$183.8K−48.2%16.1K after
Jun 17, 2025 (view filing)Jun 134 daysGalluppi StefanChief Innovation OfficerSSale−85.0K$12.38−$1.05M−51.4%80.4K after10b5-1
Jun 4, 2025 (view filing)Jun 22 daysSchreiber JustinChairman and CEOSSale−25.0K$12.47−$311.8K−1.0%2.53M after10b5-1
May 5, 2025 (view filing)May 1-24 daysSchreiber JustinChairman and CEOSSale−25.0K$7.53−$188.2K−1.0%2.55M after2 lots10b5-1
May 1, 2025 (view filing)Apr 292 daysSchreiber JustinChairman and CEOSSale−50.0K$7.78−$389.0K−1.9%2.58M after10b5-1

Top 10 13F holders, Q2 2026

The largest institutional positions in LifeMD, Inc. at the end of Q2 2026; share changes are against Q1 2026.

See all 116 holders
Institutions holding LFMD in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.3,034,535$12.5M0.00%+225,510+8.0%Added
Federated Hermes, Inc.2,747,655$11.3M0.02%+1,728,578+169.6%Added
Vanguard Capital Management LLC1,734,756$7.16M0.00%+71,060+4.3%Added
State Street Corp1,318,784$5.45M0.00%+243,376+22.6%Added
Renaissance Technologies LLC1,079,525$4.46M0.01%−38,800−3.5%Reduced
Geode Capital Management, LLC1,067,698$4.41M0.00%+48,257+4.7%Added
Prescott Group Capital Management, L.L.C.897,224$3.71M0.32%+1,800+0.2%Added
B. Riley Financial, Inc.637,319$2.63M0.61%−234,261−26.9%Reduced
Royce & Associates LP636,124$2.63M0.02%−565,527−47.1%Reduced
AQR Capital Management LLC619,506$2.56M0.00%+421,184+212.4%Added